Back
Protagonist Therapeutics Vs. Repligen Industry Stock Comparison
Sell
45
PTGX
Protagonist Therapeutics
Last Price:
31.27
Seasonality Move:
-0.18%
Sell
43
RGEN
Repligen
Last Price:
127.03
Seasonality Move:
4.1%
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $31.71. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $123.15. The Score for RGEN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $31.71
The current trend is moderately bearish and PTGX is experiencing slight selling pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 51.21 | Buy |
| Chaikin Money Flow: | -137490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.68 - 33.74) | Sell |
| Bollinger Bands (100): | (26.43 - 31.41) | Buy |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -10.58 | Sell |
| Relative Strength Index (14 RSI): | 26.78 | Sell |
| Chaikin Money Flow: | 404437 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.14 - 158.7) | Sell |
| Bollinger Bands (100): | (150.47 - 196.23) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.52 | Sell |
| 20-day SMA: | 31.85 | Sell |
| 50-day SMA: | 29.34 | Buy |
| 200-day SMA: | 23.96 | Buy |
| 8-day EMA: | 32.27 | Sell |
| 20-day EMA: | 31.89 | Sell |
| 50-day EMA: | 30.33 | Buy |
| 200-day EMA: | 25.81 | Buy |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.88 | Sell |
| 20-day SMA: | 138.24 | Sell |
| 50-day SMA: | 154.6 | Sell |
| 200-day SMA: | 167.54 | Sell |
| 8-day EMA: | 126.51 | Sell |
| 20-day EMA: | 136.68 | Sell |
| 50-day EMA: | 151.89 | Sell |
| 200-day EMA: | 167.03 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.28 per share, and an increase next year of $0.56 per share.
Protagonist Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||